This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Michael G. Wilkerson, MD; Thomas H. Connor, PhD; Jonathan K. Wilkin, MD

Arch Dermatol. 1988;124(3):396-398.

Abstract
• 2,4-Dinitrochlorobenzene (DNCB) is used for immunotherapy of alopecia areata and verruca vulgaris. We initially postulated that the presence of mutagenic contaminants in commercially available DNCB might account for part of its mutagenicity. We have now characterized changes in the dose-mutagenic response curve of 99% DNCB modified by adding 1% concentrations of known contaminants: 1-chloro-2-nitrobenzene; 1,3-dinitrobenzene; and 2,4-dichloronitrobenzene. Dose-response curves were generated using Salmonella typhimurium tester strains TA-98 and TA-100 at concentrations of 0, 1, 5, 10, 25, 50, and 100 µg per plate in a modified Ames assay. We observed a linear dose-response relationship with a slight, but nonsignificant, shift to the right when contaminants were added. We conclude that DNCB is itself mutagenic, and that contaminants play a minor role in its observed mutagenicity.

(Arch Dermatol 1988;124:396-398)

Author Affiliations
From the Departments of Dermatology (Drs Wilkerson and Wilkin) and Pharmacology (Dr Wilkin), Medical College of Virginia, Richmond; Department of Environmental Science, University of Texas School of Public Health at Houston (Dr Connor); and Dermatology Section, McGuire Veterans Administration Medical Center, Richmond, Va (Dr Wilkin).

Footnotes
Accepted for publication Oct 30, 1987.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Ames Assay and Dinitrochlorobenzene
Strick
Arch Dermatol 1988;124:1570-1570.
ABSTRACT